MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202621071381 A) filed by Secretary, Department Of Atomic Energy on June 09, 2026, for Adjuvanted Lipoplex Immunogenic Compositions, Methods Of Preparation And Uses Thereof.
Inventors include Gupta, Pramod Kumar; Shelar, Sandeep Balu; Tripathi, Devavrat; Hassan, Puthusserickal Abdulrahiman; and Kulkarni, Savita.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: The present invention relates to adjuvanted lipoplex immunogenic compositions and its use as a vaccine for inducing protective immunity against SARS-CoV-2, the causative agent of COVID-19. Existing lipid-based vaccine formulations suffer from drawbacks such as failure to provide optimal antigen presentation, lack of controlled immune stimulation and problems of instability, aggregation, or reduced potency due to physicochemical interactions between the adjuvant, the lipoplex components, and the antigen. The adjuvanted lipoplex immunogenic composition of present invention provides a safe and stable adjuvanted lipoplex vaccine platform for evoking appropriate, strong, and long lasting humoral as well as cell mediated immune response against various SARS-CoV-2 variants.
Disclaimer: Curated by HT Syndication.
